Japan
Tuberculosis profile
Population  2012 127 million
Estimates of TB burden * 2012 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 2.1 (2–2.2) 1.7 (1.6–1.7)
Mortality (HIV+TB only) <0.01 (<0.01–0.013) 0.01 (0.01–0.01)
Prevalence  (includes HIV+TB) 33 (13–61) 26 (11–48)
Incidence  (includes HIV+TB) 24 (21–28) 19 (17–22)
Incidence (HIV+TB only) 0.098 (0.085–0.11) 0.08 (0.07–0.09)
Case detection, all forms (%) 86 (76–98)    
TB case notifications 2012        
New cases   (%) Retreatment cases (%)
Smear-positive 7 663 (38) Relapse 910 (68)
Smear-negative 7 454 (37) Treatment after failure    
Smear-unknown / not done 221 (1) Treatment after default    
Extrapulmonary 4 609 (23) Other 426 (32)
Other 0 (0)      
Total new 19 947   Total retreatment 1 336  
           
Other (history unknown)          
Total new and relapse 20 857   Total cases notified 21 283  
New cases Smear-positive Smear-negative/ unknown/
not done
Extrapulmonary
M:F ratio 1.9 1.6 1.0
Age < 15 4 40 16
Laboratories 2012
Is second-line drug susceptibility testing available? Yes, in and outside
country
Treatment success rate 2011 (%)        
New smear-positive and/or culture-positive 51   Is rifampicin used
throughout treatment for
new patients?
Yes
New smear-negative/extrapulmonary 60  
Retreatment 46  
TB/HIV 2012 Number (%)
TB patients with known HIV status 3 328 (16)
HIV-positive TB patients 62 (2)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT)    
HIV-positive TB patients on antiretroviral therapy (ART)    
HIV-positive people screened for TB    
HIV-positive people provided with IPT    
Estimates of MDR-TB burden 2012*   New   Retreatment
% of TB cases with MDR-TB 0.7 (0.42–1.1) 9.8 (7.1–13)
MDR-TB cases among notified pulmonary
TB cases
110 (65–170) 130 (96–180)
Reported cases of MDR-TB 2012 New Retreatment Total
Cases tested for MDR-TB 8 564 (66%) 583 (44%) 9 147
Laboratory-confirmed MDR-TB cases 42 22 64
Patients started on MDR-TB treatment     60
Financing TB control 2013
National TB programme budget (US$ millions)  
***
(Rate per 100 000 population per year)
Mortality graph
___ Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
___ Prevalence

(Rate per 100 000 population per year)
Incidence graph
__ Notifications Incidence
___
___ Incidence (HIV+TB only)

Treatment success rate (%)
tx success graph
__ New smear-positive and/or culture-positive
__ New smear-negative/extrapulmonary __
Retreatment

(Number of patients)
CPT ART graph
__ HIV-positive TB patients
__ on CPT __ on ART

 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 * Ranges represent uncertainty intervals Generated: 2014-04-16 Data: www.who.int/tb/data